Chewy has been named the most trusted company in America in the 2026 Axios Harris Poll 100 Reputation Rankings, earning the No. 1 overall position among the nation’s most visible companies. The online pet retailer also ranked first for Trust and second for Products & Services, reflecting continued recognition of its expanding ecosystem of pet health, pharmacy, veterinary and wellness offerings.
Newly published research in Parasites & Vectors found that Elanco’s Credelio Quattro demonstrated a faster speed of kill against black-legged ticks than Simparica Trio and NexGard Plus, while maintaining efficacy throughout the monthly dosing interval. The company said the findings support the role of rapid tick control in reducing the risk of tick-borne disease transmission in dogs.
CVS Health® is bringing prescription medications for dogs and cats to nearly 9,000 CVS Pharmacy® locations across the U.S., giving pet owners another option for filling common veterinary prescriptions while adding new digital tools to simplify medication management.
Banfield Pet Hospital® has introduced customizable Optimum Wellness Plans® that allow veterinarians and pet owners to tailor preventive care based on a pet’s individual needs, while helping make veterinary expenses more predictable through monthly wellness plans.
Sylvester.ai has introduced Connect to Care, a marketing and client engagement platform that combines AI-powered feline health assessments with geo-targeted outreach to help veterinary practices attract more cat owners and increase feline appointments.
Updated with second-quarter clinical visit data and the 2026 State of the Cat household survey, the CATalyst Council’s demographic forecast for U.S. veterinary clinical visits points to a continued −2% to -1% contraction through 2035. The second edition is available in slide presentation format.
Designed to address the barriers that keep cats from receiving veterinary care, the new organization combines feline-specific medicine with national clinical leadership.
Zoetis has entered into an agreement to acquire veterinary teleradiology provider VitalRADS, a move that would significantly expand its diagnostic services portfolio by adding 24/7 specialist imaging interpretation, AI-assisted workflows, and cloud-based imaging technology. The acquisition is expected to strengthen the company’s vision for an integrated Virtual Reference Laboratory serving veterinary practices worldwide.
Early data presented at ACVIM Forum 2026 suggest Akston Biosciences’ investigational NGF-targeting Ambifect® candidates provided improvements in canine osteoarthritis pain and function comparable to bedinvetmab (Librela®). The company says the candidates also generated durable anti-NGF immune responses that may support longer dosing intervals pending further clinical evaluation.
PetSmart’s latest ranking of the nation’s most cat-loving cities highlights where feline adoption and consumer spending are strongest, offering animal health companies, veterinary marketers and pet brands a fresh look at markets with highly engaged cat owners.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.